Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Is there a neurogenetic basis for attention network differences in ADHD? 

Posted
Updated
ByMy Patient Advice
Author: Victoria Rowe, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Yes, there is growing evidence for a neurogenetic basis underlying the differences in attention networks in ADHD. Brain imaging studies, particularly using fMRI, have shown that individuals with ADHD exhibit altered connectivity in key brain regions responsible for cognitive control, focus, and attention regulation. These differences in attention networks are not only linked to structural brain changes but also to genetic factors that influence the development and functioning of the brain’s attention systems. 

Take the online ADHD test

How ADHD neurogenetics influence attention networks 

ADHD neurogenetics influence attention networks by altering neural connectivity and neurotransmitter balance, leading to difficulties in focus and sustained attention. 

Altered connectivity in attention networks  

ADHD neurogenetics studies suggest that specific genetic variants affect the brain’s attention networks, including the fronto-parietal network and cingulo-opercular network, which are critical for cognitive control and sustained attention. Functional fMRI scans reveal that these brain regions often show reduced connectivity in individuals with ADHD, leading to difficulties in managing attention and focus. 

Key ADHD-related genes 

 Genes related to dopamine regulation, such as DAT1 (dopamine transporter) and DRD4 (dopamine receptor), have been found to influence the development of attention networks. For example, variations in the DAT1 gene are associated with reduced dopamine transport in areas of the brain involved in executive function and attention control, leading to the connectivity disruptions observed in ADHD. 

Impact on cognitive control  

The altered attention networks seen in ADHD, influenced by genetic factors, can make it harder to manage cognitive tasks requiring focus, working memory, and impulse control. These disruptions are linked to genetic risk alleles, highlighting the genetic underpinnings of attention difficulties in ADHD. 

Why this matters for ADHD treatment 

Personalised treatment options  

Understanding the neurogenetic basis of attention network differences can help personalise ADHD treatment. Interventions targeting specific brain regions or cognitive functions, such as neurofeedback or medications that affect dopamine systems, could improve connectivity and attention regulation in individuals with ADHD. 

Improved diagnostic tools  

By identifying genetic markers linked to attention network differences, we may develop more accurate, objective diagnostic tools. These could complement traditional behavioural assessments, offering a more precise understanding of ADHD’s neurobiological basis. 

Long-term outcomes 

 Addressing the underlying genetic factors that influence attention network differences could lead to better long-term management of ADHD symptoms and improved cognitive control, helping individuals with ADHD succeed in daily life. 

ADHD neurogenetics attention networks is an exciting field that offers new insights into how genetic factors shape the brain’s ability to focus and regulate attention. By understanding these connections, we can develop personalised treatments that target the root causes of ADHD.  

Visit providers like ADHD Certify for personal consultations that integrate genetic and neurogenetic insights into ADHD management. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Genetic studies and biomarkers.

Take the online ADHD test
Victoria Rowe, MSc
Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories